Wordt geladen...
CSF β-amyloid 1-42 predicts progression to cognitive impairment in newly diagnosed Parkinson disease
BACKGROUND: Low CSF β-amyloid 1-42 has been associated with cognitive decline in advanced Parkinson’s Disease; data from a single cohort suggest β-amyloid 1-42 may be an early marker of cognitive impairment. DESIGN/METHODS: Newly diagnosed Parkinson’s participants (mean duration: 6.9 months) in the...
Bewaard in:
| Gepubliceerd in: | J Mol Neurosci |
|---|---|
| Hoofdauteurs: | , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
2015
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4738011/ https://ncbi.nlm.nih.gov/pubmed/26330275 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12031-015-0647-x |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|